ETFs for Hedge Funds’ Favorite Pharma Stocks
August 25, 2014 at 13:03 PM EDT
Merger mania in the health care sector is on full display Monday after Swiss pharmaceuticals giant Roche announced Sunday it will acquire InterMune (NasdaqGS: ITMN) for $8.3 billion in cash. The news, which has bolstered shares of several biotechnology exchange traded funds that hold shares of...